SLNO - Soleno Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-09-16)
Last
 49.71		 Change
 ⇓ -1.46   (-2.85%)		 Volume
  2,609,697
Open
 51.15		 High
 51.24		 Low
 48.91
8EMA (Daily)
 57.76		 40EMA (Daily)
 70.09		 50EMA (Daily)
 71.41		 STO (Daily)
 17.668		 MACD Hist (Daily)
 -3.536
8EMA (Weekly)
 65.276		 40EMA (Weekly)
 66.27		 50EMA (Weekly)
 63.79		 STO (Weekly)
 13.531		 MACD Hist (Weekly)
 -8.670
Company Profile
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com